Literature DB >> 33760926

[Imaging in metastatic prostate cancer].

C-H Ohlmann1.   

Abstract

Entities:  

Year:  2021        PMID： 33760926     DOI： 10.1007/s00120-021-01507-7

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  2 in total

1.  Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.

Authors:  A H Bryce; J J Alumkal; A Armstrong; C S Higano; P Iversen; C N Sternberg; D Rathkopf; Y Loriot; J de Bono; B Tombal; S Abhyankar; P Lin; A Krivoshik; D Phung; T M Beer
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-01-24       Impact factor: 5.554

2.  Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer.

Authors:  Stefano Fanti; Karolien Goffin; Boris A Hadaschik; Ken Herrmann; Tobias Maurer; Steven MacLennan; Daniela E Oprea-Lager; Wim Jg Oyen; Olivier Rouvière; Nicolas Mottet; Anders Bjartell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-02       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.